These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9153920)

  • 1. [Genetic defects in neurodegenerative diseases].
    Davidson B; Nass D
    Harefuah; 1997 Apr; 132(7):481-5. PubMed ID: 9153920
    [No Abstract]   [Full Text] [Related]  

  • 2. Tales of Pacific tangles: Cycad exposure and Guamanian neurodegenerative diseases.
    Friedland RP; Armon C
    Neurology; 2007 May; 68(21):1759-61. PubMed ID: 17515536
    [No Abstract]   [Full Text] [Related]  

  • 3. The genetics of motor neurone disease.
    Vassilopoulos D
    Prog Clin Biol Res; 1989; 306():91-104. PubMed ID: 2662216
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neurodegenerative disorders and the role of trinucleotide repeat expansion].
    Kranendonk O
    Ned Tijdschr Geneeskd; 1997 Feb; 141(8):400-1. PubMed ID: 9157308
    [No Abstract]   [Full Text] [Related]  

  • 5. Central/nervous system/neuromuscularchannelopathies.
    Zuberi SM
    Eur J Paediatr Neurol; 2001; 5(5):207-9. PubMed ID: 11585110
    [No Abstract]   [Full Text] [Related]  

  • 6. [An autopsy case of amyotrophic lateral sclerosis/parkinsonism-dementia complex with family history and living history in the Kii Peninsula focus].
    Konagaya M; Kato T; Sakai M; Kuru S; Matsuoka Y; Hashizume Y
    Rinsho Shinkeigaku; 1999 Nov; 39(11):1118-24. PubMed ID: 10689933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic testing for neuromuscular disorders].
    Yoshida K
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():183-9. PubMed ID: 16416792
    [No Abstract]   [Full Text] [Related]  

  • 8. [Triplet repeat disorders: from the clinical view].
    Komure O; Ueno S; Sano A
    Tanpakushitsu Kakusan Koso; 1997 Aug; 42(11):1840-57. PubMed ID: 9279119
    [No Abstract]   [Full Text] [Related]  

  • 9. Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases.
    Bogaert E; Van Damme P; Van Den Bosch L; Robberecht W
    Muscle Nerve; 2006 Oct; 34(4):391-405. PubMed ID: 16856151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical and pathological study of a Japanese case of Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex with family history.
    Konagaya M; Kato T; Sakai M; Kuru S; Matsuoka Y; Konagaya Y; Hashizume Y; Tabira T
    J Neurol; 2003 Feb; 250(2):164-70. PubMed ID: 12574946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postencephalitic Parkinson's disease, amyotrophic lateral sclerosis on Guam and influenza revisited: focusing on neurofibrillary tangles and the trail of tau.
    Maurizi CP
    Med Hypotheses; 2002 Mar; 58(3):198-202. PubMed ID: 12018970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic studies in neurology].
    Lechner-Scott J; Steck AJ; Scott RJ
    Schweiz Med Wochenschr; 1997 Jun; 127(26):1141-53. PubMed ID: 9312837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene table. Central nervous system/neuromuscular channelopathies.
    Zuberi SM
    Eur J Paediatr Neurol; 2003; 7(4):187-90. PubMed ID: 12865060
    [No Abstract]   [Full Text] [Related]  

  • 14. [Approaches from genetical analyses on human diseases: neurodegenerative diseases].
    Kakizuka A
    Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):792-7. PubMed ID: 10771635
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuromuscular dysfunction in the mutant superoxide dismutase mouse model of amyotrophic lateral sclerosis.
    Parkhouse WS; Cunningham L; McFee I; Miller JM; Whitney D; Pelech SL; Krieger C
    Amyotroph Lateral Scler; 2008; 9(1):24-34. PubMed ID: 18273716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does VEGF represent a potential treatment for amyotrophic lateral sclerosis?
    Iłzecka J
    Curr Opin Investig Drugs; 2006 Jan; 7(1):54-9. PubMed ID: 16425672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders.
    Treves S; Anderson AA; Ducreux S; Divet A; Bleunven C; Grasso C; Paesante S; Zorzato F
    Neuromuscul Disord; 2005 Oct; 15(9-10):577-87. PubMed ID: 16084090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and experimental neuroprotection in neurodegenerative diseases is a therapeutic option for the future of amyotrophic lateral sclerosis (ALS). Preface.
    Ludolph AC; Drory VE
    J Neurol; 2000 Dec; 247 Suppl 6():VI/1. PubMed ID: 19714407
    [No Abstract]   [Full Text] [Related]  

  • 19. Genes and the environment in neurodegeneration.
    Coppedè F; Mancuso M; Siciliano G; Migliore L; Murri L
    Biosci Rep; 2006 Oct; 26(5):341-67. PubMed ID: 17029001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment in neuromuscular disorders.
    D'Angelo MG; Bresolin N
    Muscle Nerve; 2006 Jul; 34(1):16-33. PubMed ID: 16544320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.